Evidence map›Paper›PMID 33920048›Full record

ArticleInternational journal of molecular sciences2021

Neuroinflammatory Response to TNFα and IL1β Cytokines Is Accompanied by an Increase in Glycolysis in Human Astrocytes In Vitro.

David Pamies, Chiara Sartori, Domitille Schvartz, Víctor González-Ruiz, Luc Pellerin, Carolina Nunes, Denise Tavel, Vanille Maillard, Julien Boccard, Serge Rudaz and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Lesion level and severity acutely influence metabolomic profiles in spinal cord injury.Journal of neuropathology and experimental neurology · 2026
    Article
  10. Review
  11. Silmitasertib, an FDA-designated orphan CK2 inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse model.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Heat-KilledJournal of microbiology and biotechnology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

David PamiesDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.
Chiara SartoriDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.
Domitille SchvartzSwiss Centre for Applied Human Toxicology (SCAHT), 4055 Basel, Switzerland.ORCID 0000-0003-1133-0462
Víctor González-RuizSwiss Centre for Applied Human Toxicology (SCAHT), 4055 Basel, Switzerland.ORCID 0000-0001-7204-2363
Luc PellerinDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.ORCID 0000-0002-1016-1970
Carolina NunesDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.ORCID 0000-0001-8503-1719
Denise TavelDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.
Vanille MaillardDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.
Julien BoccardSwiss Centre for Applied Human Toxicology (SCAHT), 4055 Basel, Switzerland.ORCID 0000-0001-5913-9566
Serge RudazSwiss Centre for Applied Human Toxicology (SCAHT), 4055 Basel, Switzerland.ORCID 0000-0002-4180-5417
Jean-Charles SanchezSwiss Centre for Applied Human Toxicology (SCAHT), 4055 Basel, Switzerland.
Marie-Gabrielle ZurichDepartment of Biomedical Sciences, University of Lausanne, CH-1005 Lausanne, Switzerland.ORCID 0000-0002-3168-5968
Swiss Centre for Applied Human ToxicologyUniversity of Geneva · CHInserm · FRUniversity of Lausanne · CH

Funding

Swiss Centre for Applied Human Toxicology CP3
6 · The paper itself

Abstract

Astrogliosis has been abundantly studied in rodents but relatively poorly in human cells due to limited access to the brain. Astrocytes play important roles in cerebral energy metabolism, and are also key players in neuroinflammation. Astroglial metabolic and inflammatory changes as a function of age have been reported, leading to the hypothesis that mitochondrial metabolism and inflammatory responses are interconnected in supporting a functional switch of astrocytes from neurotrophic to neurotoxic. This study aimed to explore the metabolic changes occurring in astrocytes during their activation. Astrocytes were derived from human ReN cell neural progenitors and characterized. They were activated by exposure to tumor necrosis factor alpha (TNFα) or interleukin 1β (IL1β) for 24 h. Astrocyte reaction and associated energy metabolic changes were assessed by immunostaining, gene expression, proteomics, metabolomics and extracellular flux analyses. ReN-derived astrocytes reactivity was observed by the modifications of genes and proteins linked to inflammation (cytokines, nuclear factor-kappa B (NFκB), signal transducers and activators of transcription (STATs)) and immune pathways (major histocompatibility complex (MHC) class I). Increased NFκB1, NFκB2 and STAT1 expression, together with decreased STAT3 expression, suggest an activation towards the detrimental pathway. Strong modifications of astrocyte cytoskeleton were observed, including a glial fibrillary acidic protein (GFAP) decrease. Astrogliosis was accompanied by changes in energy metabolism characterized by increased glycolysis and lactate release. Increased glycolysis is reported for the first time during human astrocyte activation. Astrocyte activation is strongly tied to energy metabolism, and a possible association between NFκB signaling and/or MHC class I pathway and glycolysis is suggested.

Indexed as

AstrocytesBrainCell LineEnergy MetabolismGliosisGlycolysisHumansInflammationInterleukin-1betaNeurogenesisSignal TransductionSTAT3 Transcription FactorTumor Necrosis Factor-alphaIL1B protein, humanInterleukin-1betaSTAT3 protein, humanSTAT3 Transcription FactorTumor Necrosis Factor-alphaastrocytesastrogliosisenergy metabolismneuroenergeticneuroinflammationreactive astrocytes

Identifiers

PMID33920048
PMCPMC8071021
OpenAlexW3152614995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.